当前位置: X-MOL 学术Proc. Natl. Acad. Sci. U.S.A. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
SARS-CoV-2 spike does not interact with the T cell receptor or directly activate T cells
Proceedings of the National Academy of Sciences of the United States of America ( IF 9.4 ) Pub Date : 2024-07-23 , DOI: 10.1073/pnas.2406615121
Stephanie A Gaglione 1, 2 , Tatiana J Rosales 3, 4 , Laura Schmidt-Hong 2, 5 , Brian M Baker 3, 4 , Michael E Birnbaum 2, 5, 6
Affiliation  

SARS-CoV-2 infection can induce multisystem inflammatory syndrome in children, which resembles superantigen-induced toxic shock syndrome. Recent work has suggested that the SARS-CoV-2 spike (S) protein could act as a superantigen by binding T cell receptors (TCRs) and inducing broad antigen-independent T cell responses. Structure-based computational modeling identified potential TCR-binding sites near the S receptor-binding domain, in addition to a site with homology to known neurotoxins. We experimentally examined the mechanism underpinning this theory—the direct interaction between the TCR and S protein. Surface plasmon resonance of recombinantly expressed S protein and TCR revealed no detectable binding. Orthogonally, we pseudotyped lentiviruses with SARS-CoV-2 S in both wild-type and prefusion-stabilized forms, demonstrated their functionality in a cell line assay, and observed no transduction, activation, or stimulation of proliferation of CD8 + T cells. We conclude that it is unlikely that the SARS-CoV-2 spike protein engages nonspecifically with TCRs or has superantigenic character.

中文翻译:


SARS-CoV-2 刺突不与 T 细胞受体相互作用或直接激活 T 细胞



SARS-CoV-2感染可诱发儿童多系统炎症综合征,类似于超抗原诱发的中毒性休克综合征。最近的研究表明,SARS-CoV-2 刺突 (S) 蛋白可以通过结合 T 细胞受体 (TCR) 并诱导广泛的不依赖于抗原的 T 细胞反应来充当超级抗原。基于结构的计算模型除了与已知神经毒素具有同源性的位点外,还确定了 S 受体结合域附近潜在的 TCR 结合位点。我们通过实验检验了支撑这一理论的机制——TCR 和 S 蛋白之间的直接相互作用。重组表达的 S 蛋白和 TCR 的表面等离子共振显示没有可检测到的结合。正交地,我们用野生型和融合前稳定形式的 SARS-CoV-2 S 假型化慢病毒,在细胞系测定中证明了它们的功能,并且没有观察到 CD8 的转导、激活或增殖刺激+ T细胞。我们的结论是,SARS-CoV-2 刺突蛋白不太可能与 TCR 非特异性结合或具有超抗原特性。
更新日期:2024-07-23
down
wechat
bug